Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

José Baselga, Debu Tripathy, John Mendelsohn, +11

Journal of Clinical Oncology

Hyperthermic Oncology 1984

Helen R. Griffiths, J. Moore

International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine

Hyperthermic Oncology 1984HyperthermiaMedicineCancer ManagementOncology +2

Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer.

José Baselga, Debu Tripathy, J. Mendelsohn, +11

PubMed

Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.

Z Arlin, Delvyn C. Case, J. Moore, +6

PubMed

A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily

Philip Savage, Vicki L. Horton, J. Moore, +3

British Journal of Cancer

ImmunodeficienciesImmunologyOral Interferon InducerPharmacotherapyMedicine

Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer

Ana M. González-Angulo, Argun Akçakanat, S. Liu, +23

Annals of Oncology

Breast OncologyMedicineStandard Neoadjuvant ChemotherapyBreast CancerCancer Treatment +3

Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer

Helmout Modjtahedi, Tamas Hickish, Margery Nicolson, +10

British Journal of Cancer

Malignant DiseaseMedicineImmunologyPathologyBronchial Neoplasm +8

Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-α) and interleukin (IL-2) in patients with metastatic melanoma

SR Johnston, D CONSTENLA, J. Moore, +5

British Journal of Cancer

Phase Ii TrialMedicineMelanomaImmunologyTumor Immunity +11

Gene Therapy with Autologous, Interleukin 2-Secreting Tumor Cells in Patients with Malignant Melanoma

Kay Palmer, J. Moore, M. Everard, +13

Human Gene Therapy

Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer: a phase II study

Mark Allen, Matthew Vaughan, Andrew Webb, +7

British Journal of Cancer